November 2021 News from our Partners at Consultant 360

Sara Reece, PharmD, CDCES, on GLP-1 Agonists and SGLT-2 Inhibitors for Patients With Diabetes
In this Q&A, Sara Reece, PharmD, CDCES, discusses the use of GLP-1 agonists and SGLT-2 inhibitors to improve cardiovascular and renal outcomes in patients with type 2 diabetes.

Maura Jones, PharmD, BCPS, on Lipid Management for Patients With Diabetes
In this podcast, Maura Jones, PharmD, BCPS, discusses clinical practice guidelines and various medication regimens for managing cardiovascular disease risks in patients with diabetes. This was a topic she recently presented on at ADCES21.

Wanqing Liu, PhD, on NAFLD, Type 2 Diabetes, and Obesity
Researchers conducted a study of genomic data to clarify the relationships among nonalcoholic fatty liver disease, type 2 diabetes, and obesity. Lead author Wanqing Liu, PhD, answered our questions about the study.

Sri Banerjee, MD, PhD, MPH, MAS, on Depression and Diabetes
In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, speaks about his research on the effects of depression on diabetes, including common physiological pathways that would explain a connection between physical and mental health, and screening tools used to monitor cases of depression. 

 Chandler Howell, PharmD, on Disparities in Outpatient Management of Type 2 Diabetes
In this podcast, Chandler Howell, PharmD, speaks about the guideline-recommended first and second-line treatment options for type 2 diabetes, the pharmacist involvement in the care of people with diabetes, and gaps that exist in access to medication for people with fewer financial resources. He presented on this topic at ADCES21.